American ginseng improves neurocognitive function in senescence-accelerated mice: Possible role of the upregulated insulin and choline acetyltransferase gene expression

Geriatrics and Gerontology International

Volumn 12, Issue 1, 2012, Pages 123-130

  Shi, Shun ^a   Shi, Reika ^a   Hashizume, Kiyoshi ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

American ginseng; Choline acetyltransferase; Insulin; Neurocognitive function; Senescence accelerated mouse

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CHOLINE; CHOLINE ACETYLTRANSFERASE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BRAIN FUNCTION; COGNITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FOOD INTAKE; GENE EXPRESSION; GINSENG; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LEARNING; MALE; MEMORY; MENTAL PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENESCENCE; UPREGULATION; WEIGHT CHANGE;

AGING; ANIMALS; CHOLINE O-ACETYLTRANSFERASE; COGNITION; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HIPPOCAMPUS; INSULIN; MALE; MICE; MICE, INBRED STRAINS; PANAX; PLANT PREPARATIONS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 84155195352     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2011.00719.x     Document Type: Article

References (46)

1. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 1999; 53: 1937-1942.
2. Sakurai T, Yokono K. Comprehensive studies of cognitive impairment of the elderly with type 2 diabetes. Geriatr Gerontol Int 2006; 6: 159-164.
3. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 2004; 53: 474-481.
4. Sloley BD, Pang PK, Huang BH etal. American ginseng extract reduces scopolamine-induced amnesia in a spatial learning task. J Psychiatry Neurosci 1999; 24: 442-452.
5. Scholey A, Ossoukhova A, Owen L etal. Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomized, double-blind, placebo-controlled, crossover study. Psychopharmacology (Berl) 2010; 212: 345-356.
6. Reay JL, Kennedy DO, Scholey AB. Single doses of Panax ginseng (G115) reduces blood glucose levels and improve cognitive performance during sustained mental activity. J Psychopharmacol 2005; 19: 357-365.
7. Banz WJ, Iqbal MJ, Bollaert M etal. Ginseng modifies the diabetic phenotype and genes associated with diabetes in the male ZDF rat. Phytomedicine 2007; 14: 681-689.
8. Vuksan V, Sievenpiper JL, Koo VY etal. American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med 2000; 160: 1009-1013.
9. Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 1995; 18: 1373-1375.
10. Chen CF, Chiou WF, Zhang JT. Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium. Acta Pharmacol Sin 2008; 29: 1103-1108.
11. Xiang YZ, Shang HC, Gao XM, Zhang BL. A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials. Phytother Res 2008; 22: 851-858.
12. Takeda T, Hosokawa M, Takeshita S etal. A new murine model of accelerated senescence. Mech Ageing Dev 1981; 17: 183-194.
13. Hosokawa M, Kasai R, Higuchi K etal. Grading score system: a method for evaluation of the degree of senescence in senescence accelerated mouse (SAM). Mech Ageing Dev 1984; 26: 91-102.
14. Shimada A, Ohta A, Akiguchi I, Takeda T. Inbred SAM-P/10 as a mouse model of spontaneous, inherited brain atrophy. J Neuropathol Exp Neurol 1992; 51: 440-450.
15. Miyamoto M. Characteristics of age-related behavioral changes in senescence-accelerated mouse SAMP8 and SAMP10. Exp Gerontol 1997; 32: 139-148.
16. Shimada A. Age-dependent cerebral atrophy and cognitive dysfunction in SAMP10 mice. Neurobiol Aging 1999; 20: 125-136.
17. Shimada A, Keino H, Satoh M, Kishikawa M, Hosokawa M. Age-related loss of synapses in the frontal cortex of SAMP10 mouse: a model of cerebral degeneration. Synapse 2003; 48: 198-204.
18. Takeda T. Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice. Neurochem Res 2009; 34: 639-659.
19. Kurokawa M, Fujimura K, Sakurai-Yamashita Y. A new-generation apparatus for studying memory-related performance in mice. Cell Mol Neurobiol 2003; 23: 121-129.
20. Nagai J, Kurokawa M, Takeshima H, Kieffer BL, Ueda H. Circadian-dependent learning and memory enhancement in nociceptin receptor-deficient mice with a novel KUROBOX apparatus using stress-free positive cue task. J Pharmacol Exp Ther 2007; 321: 195-201.
21. de la Monte SM, Wands JR. Role of central nervous system insulin resistance in fetal alcohol spectrum disorders. J Popul Ther Clin Pharmacol 2010; 17: e390-e404.
22. de la Monte SM, Wands JR. Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease. J Alzheimers Dis 2006; 9: 167-181.
23. Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J Alzheimers Dis 2005; 8: 247-268.
24. van der Heide LP, Ramakers GM, Smidt MP. Insulin signaling in the central nervous system: learning to survive. Prog Neurobiol 2006; 79: 205-221.
25. Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behav Brain Res 2011; 221: 555-563.
26. Chow VW, Mattson MP, Wong PC, Gleichmann M. An overview of APP processing enzymes and products. Neuromolecular Med 2009; 12: 1-12.
27. Morley JE, Kumar VB, Bernardo AE etal. Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 2000; 21: 1761-1767.
28. de la Monte SM, Tong M, Lester-Coll N, Plater M Jr, Wands JR. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. J Alzheimers Dis 2006; 10: 89-109.
29. Moriguchi T, Saito H, Nishiyama N. Anti-ageing effect of aged garlic extract in the inbred brain atrophy mouse model. Clin Exp Pharmacol Physiol 1997; 24: 235-242.
30. Fu Y, Ji LL. Chronic ginseng consumption attenuates age-associated oxidative stress in rats. J Nutr 2003; 133: 3603-3609.
31. Lee TK, O'Brien KF, Wang W etal. American ginseng modifies Cs-induced DNA damage and oxidative stress in human lymphocytes. Open Nucl Med J 2009; 1: 1-8.
32. Li J, Huang M, Teoh H, Man RY. Panax quinquefolium saponins protects low density lipoproteins from oxidation. Life Sci 1999; 64: 53-62.
33. Xie JT, Shao ZH, Vanden Hoek TL etal. Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur J Pharmacol 2006; 532: 201-207.
34. Romano AD, Serviddio G, de Matthaeis A, Bellanti F, Vendemiale G. Oxidative stress and aging. J Nephrol 2010; 23 (Suppl 15): S29-S36.
35. Nelson TJ, Sun MK, Hongpaisan J, Alkon DL. Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. Eur J Pharmacol 2008; 585: 76-87.
36. Broughton S, Partridge L. Insulin/IGF-like signalling, the central nervous system and aging. Biochem J 2009; 418: 1-12.
37. de la Monte SM, Wands JR. Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol 2008; 2: 1101-1113.
38. de la Monte SM, Wands JR. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis 2005; 7: 45-61.
39. Kroner Z. The relationship between Alzheimer's disease and diabetes: type 3 diabetes? Altern Med Rev 2009; 14: 373-379.
40. Salim KN, McEwen BS, Chao HM. Ginsenoside Rb1 regulates ChAT, NGF and trkA mRNA expression in the rat brain. Brain Res Mol Brain Res 1997; 47: 177-182.
41. Luo JZ, Luo L. Ginseng on hyperglycemia: effects and mechanisms. Evid Based Complement Alternat Med 2009; 6: 423-427.
42. Peng DC, Chen WP, Xie JT. Antihyperglycemic effects of ginseng and possible mechanisms. Drugs Future 2008; 33: 507-514.
43. Luo JZ, Luo L. American ginseng stimulates insulin production and prevents apoptosis through regulation of uncoupling protein-2 in cultured beta cells. Evid Based Complement Alternat Med 2006; 3: 365-372.
44. Collingwood A, Eagleton J, Tse R eds. What Is Dual Modulation [Monograph on the Internet]. Hong Kong: Integrated Chinese Medicine Holdings Ltd. [Cited Jan 5 2011]. Available from:
45. Chen JX, Tang YT. Effect of Xiaoyao powder on changes of relative brain zone CRF gene expression in chronic restrained stress rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2004; 20: 71-74.
46. Messier C. Glucose improvement of memory: a review. Eur J Pharmacol 2004; 490: 33-57.